Medicare Policy Change Could Increase Inequity in Heart Transplant Access, Study Finds

Loading

Patients seen at transplant centers had almost 80% higher odds to receive “bridge-to-transplant” designation

January 13, 2023 — A change to Medicare policy surrounding heart transplant may lead to increased inequities in access to transplant for patients with heart failure, a Michigan Medicine study finds.

When a patient has severe heart failure, both a heart transplant and left ventricular assist device, which is implanted to assist the heart in improving blood circulation throughout the body, can be lifesaving. While LVADs continue to improve, heart transplant remains the gold standard therapy for end-stage heart failure. Read more in Diagnostic and Interventional Cardiology (DAIC).

Loading

Testing for coronary heart disease before kidney transplant may not lower adverse outcomes

Loading

Testing for coronary heart disease within 12 months before kidney transplantation did not correlate with a change in death or myocardial infarction within 30 days after the transplant, according to data published in JAMA Internal Medicine.

Therefore, researchers suggest that testing for coronary heart disease (CHD) may not reduce the risk of adverse outcomes after a transplant. Read more in Healio.

Loading

The Gift of Life Is Multiplied Exponentially with Whole-Body Donation

Loading

When Alva Capuano was discovered unconscious in her living room, her husband, Richard, and then paramedics did everything possible to get her heart beating again. But by the time it did, her brain had experienced irreversible damage. Her family accepted that Alva, 64, was gone. Their sorrow fueled a determination to fulfill her last wish: As the recipient of a donated pancreas and kidney, Alva had hoped to become an organ donor herself.
Read the article from NYU Langone Health NewsHub.

Loading

Medicare policy change could increase inequity in heart transplant access, study finds

Loading

Patients seen at transplant centers had almost 80% higher odds to receive “bridge-to-transplant” designation

A change to Medicare policy surrounding heart transplant may lead to increased inequities in access to transplant for patients with heart failure, a Michigan Medicine study finds.

When a patient has severe heart failure, both a heart transplant and left ventricular assist device, which is implanted to assist the heart in improving blood circulation throughout the body, can be lifesaving. While LVADs continue to improve, heart transplant remains the gold standard therapy for end-stage heart failure.
Read more from University of Michigan Health.

Loading

Fixing Heart Failure Workforce Issues: Baby Steps Start This Year

Loading

— Pay, curriculum changes proposed to attract more doctors

This spring, discussions on how to build a workforce that better meets the needs of the heart failure population will begin in earnest.

The alarming number of unfilled fellowship spots for advanced heart failure and transplant cardiology (AHFTC) each year shows that the field is not enticing new trainees, despite the growing clinical need and advances in therapeutics. Read more in MedPage Today.

Loading

Top cardiology news in 2022: Successful xenotransplants; statins vs. supplements; and more

Loading

Healio and Cardiology Today have compiled a list of the most-read news of 2022 in cardiology.

Readers were most interested in a meta-analysis questioning the association between statin-induced LDL lowering and CV outcomes; firsts in xenotransplantation of genetically modified pig hearts; how moderate wine intake with meals may reduce type 2 diabetes risk; and more. Read the full story in Healio.

Loading

FDA clears AI-guided device to diagnose HFpEF from a single echocardiogram

Loading

Ultromics announced its artificial intelligence-guided device for the diagnosis of HF with preserved ejection fraction via echocardiogram has received full marketing authorization from the FDA.

The device (EchoGo Heart Failure) was developed by Ultromics, a spin-out of the University of Oxford, in collaboration with Mayo Clinic, according to a press release issued by the company.
Read the full story in Healio.

Loading